Why Cann, Clinuvel, Nufarm, & Ramelius shares stormed higher today

In afternoon trade the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to continue its poor run with another decline. At the time of writing the benchmark index is down 0.25% to 6,149.9 points.

Four shares that have not let that hold them back today are listed below. Here’s why they have stormed higher:

The Cann Group Ltd (ASX: CAN) share price has jumped 9% to $2.19. The cannabis company’s shares have been strong performers this week after announcing an agreement to purchase a site located within the Mildura region for $10.75 million. The company plans to construct a state-of-the-art greenhouse on the site which will have a production capacity of up to 50,000 kilograms of dry flower per annum.

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has bounced back from a selloff on Wednesday and is up 4% to $27.39. The biopharmaceutical company’s shares fell as much as 26% yesterday despite there being no news out of it. A large number of shares were sold, but at this stage it is unclear who was doing the selling.

The Nufarm Limited (ASX: NUF) share price has rebounded 6% higher to $4.48. On Wednesday the crop protection and specialist seed company’s shares were hammered after the release of its half year results. Due to tough conditions in Australia, the company suspended its dividend and cut it full year guidance. This morning analysts at Morgans upgraded its shares to an add rating with a $6.30 price target. Although its result was far worse than expected, it sees the share price weakness as a buying opportunity.

The Ramelius Resources Limited (ASX: RMS) share price has jumped 7% higher to 84.5 cents. Investors have been buying Australian gold miners today after the spot gold price pushed higher overnight. The precious metal price climbed higher after the U.S. Federal Reserve announced that it would not increase rates any further in 2019. The S&P/ASX All Ords Gold index is up 1.3% at the time of writing.

Missed these gains? Then don't miss out on these top shares that have been tipped to shine.

Top 3 ASX Blue Chips To Buy For 2019

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!